NBIX Performance: 40.4% Return (12 Months)

NBIX returned 40.4% over 12 months, outperforming the S&P 500 (32.2%). Volatility: 33.2%.

RS IBD 12.03
Top 77% in Peers
Volatility 33.2%
Top 7% in Peers
Total Return 12m 40.38%
Top 72% in Peers
RS Rating 46.03
Top 77% in Peers
P/E
P/E Trailing 28.4
P/E Forward 23.2
High / Low 52w
52 Week High 155.63 USD
52 Week Low 87.54 USD
Sentiment
VRO Trend Strength ±100 43.86
Buy Signal ±3 0.40
Drawdowns 3y
Max Drawdown 42.89%
Mean Drawdown 10.42%
Compare performance with 200 peers in Biotechnology
12m Total Return: NBIX (40.4%) vs PEER ETF Total Return of Neurocrine Biosciences versus broad market ETF SPY
5y Drawdown (Underwater) Chart 5 Year Drawdown / Underwater Chart for NBIX Performance: 40.4% Return (12 Months)

Top Performer in Biotechnology (5/200)

Short Term Performance
SYMBOL 1W 1M 3M
ERAS 5.44% 8.25% 229.98%
ORKA 23.55% 80.09% 117.91%
CNTA -0.43% 51.59% 74.31%
KOD 9.63% 62.48% 54.38%
APLS 1.17% 103.60% 53.64%
NBIX -0.64% 0.75% -6.91%
Long Term Performance
SYMBOL 6M 12M 5Y
ABVX 33.87% 2127.15% 904.14%
ABVX 34.71% 1952.58% 410.51%
KOD 193.68% 1816.97% -61.69%
TNGX 171.60% 1459.06% 76.00%
ERAS 587.90% 1292.65% -2.12%
NBIX -4.45% 40.38% 40.22%
Overall Best Picks of Peer Group (GARP Metrics)
SYMBOL MCAP 1M 12M 5Y P/E P/E fwd PEG EPS stab EPS cagr
ROIV NASDAQ
Roivant Sciences		 20.3B -6.03% 200% 182% - - - 37.2% -14.4%
UTHR NASDAQ
United Therapeutics		 24.8B 6.90% 93.9% 178% 20.3 20.0 2.25 -2.20% -35.9%
DAWN NASDAQ
Day One Biopharmaceuticals		 2.22B 0.61% 206% -17.1% - - - 57.3% 49.0%
FOLD NASDAQ
Amicus Therapeutics		 4.53B 0.70% 102% 57.5% - 30.5 -0.18 83.6% 131%
GLUE NASDAQ
Monte Rosa Therapeutics		 1.37B -3.06% 322% -19.2% - 10.9 - 59.8% 43.8%
KRYS NASDAQ
Krystal Biotech		 7.65B 2.06% 59.0% 281% 38.3 45.1 - 84.4% 26.5%
STRO NASDAQ
Sutro Biopharma		 394M 2.92% 258% -87.2% - 8.96 - -29.4% -68.0%
AUPH NASDAQ
Aurinia Pharmaceuticals		 2.08B 9.88% 108% 23.4% 7.54 22.7 - 63.8% 123%
TVTX NASDAQ
Travere Therapeutics		 2.94B 9.28% 109% 23.7% - 46.5 - 82.4% 24.9%
APLS NASDAQ
Apellis Pharmaceuticals		 5.20B 104% 106% -2.07% 226 46.3 - 76.9% 53.7%

Performance: NBIX vs S&P 500

Total Return vs S&P 500
PERIOD NBIX S&P 500 DIFFERENCE
1 Month 0.75% -2.54% 3.38%
3 Months -6.91% -4.14% -2.89%
6 Months -4.45% -0.92% -3.57%
12 Months 40.38% 32.20% 6.18%
5 Years 40.22% 71.53% -18.25%

NBIX Performance FAQ

Does NBIX outperform the market?

Yes, NBIX significantly outperforms the market. Over the past 12 months, NBIX returned 40.38% compared to 32.20% for the S&P 500.

What is the NBIX return over the last 12 months?

NBIX has returned 40.38% over the past 12 months, including dividends. Over 3 months the return was -6.91%, and over 5 years 40.22%.

How risky is NBIX?

NBIX has relatively low risk with a maximum drawdown of 42.89% over the past 3 years. The average drawdown is 10.42%.

NBIX vs Sectors (12m)

Sorted by outperformance. Positive = NBIX beats sector.

Relative Performance vs S&P Sectors
SECTOR ETF DIFFERENCE 12M
Consumer Staples XLP 32.7%
Health Care XLV 29.4%
Real Estate XLRE 26.8%
Financials XLF 25.5%
Consumer Discretionary XLY 20.1%
Communication Services XLC 10.8%
Communication Services XLC 10.8%
Materials XLB 7.1%
Industrials XLI -1.5%
Technology XLK -10.3%
Energy XLE -18.3%

NBIX vs Asset Classes (12m)

Relative Performance vs Major Asset Classes
ASSET CLASS ETF DIFFERENCE 12M
S&P 500 SPY 6.18%
Gold GLD -17.4%
Long-Term Bonds TLT 39.8%